Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

852 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer.
Oka M, Fukuda M, Fukuda M, Kinoshita A, Kuba M, Ichiki M, Rikimaru T, Soda H, Takatani H, Narasaki F, Nagashima S, Nakamura Y, Hayashi N, Kohno S. Oka M, et al. Among authors: kinoshita a. Eur J Cancer. 2001 Jul;37(11):1359-65. doi: 10.1016/s0959-8049(01)00099-5. Eur J Cancer. 2001. PMID: 11435065 Clinical Trial.
Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer.
Oka M, Fukuda M, Kuba M, Ichiki M, Rikimaru T, Soda H, Tsurutani J, Nakamura Y, Kawabata S, Nakatomi K, Narasaki F, Nagashima S, Takatani H, Fukuda M, Kinoshita A, Kohno S. Oka M, et al. Among authors: kinoshita a. Eur J Cancer. 2002 Oct;38(15):1998-2004. doi: 10.1016/s0959-8049(02)00191-0. Eur J Cancer. 2002. PMID: 12376204 Clinical Trial.
Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia.
Nakamura Y, Soda H, Oka M, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Nagashima S, Soejima Y, Kasai T, Nakatomi K, Masuda N, Tsukamoto K, Kohno S. Nakamura Y, et al. Among authors: kinoshita a. J Thorac Oncol. 2011 Jan;6(1):121-7. doi: 10.1097/JTO.0b013e318200e4e8. J Thorac Oncol. 2011. PMID: 21150467 Free article. Clinical Trial.
Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer.
Tomonaga N, Nakamura Y, Soda H, Nagashima S, Nakano H, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Soejima Y, Oka M, Kohno S; Nagasaki Thoracic Oncology Group. Tomonaga N, et al. Among authors: kinoshita a. Cancer Chemother Pharmacol. 2008 Jun;62(1):43-9. doi: 10.1007/s00280-007-0571-z. Epub 2007 Aug 24. Cancer Chemother Pharmacol. 2008. PMID: 17717667 Clinical Trial.
Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.
Oka M, Fukuda M, Nagashima S, Fukuda M, Kinoshita A, Soda H, Doi S, Narasaki F, Suenaga M, Takatani H, Nakamura Y, Kawabata S, Tsurutani J, Kanda T, Kohno S. Oka M, et al. Among authors: kinoshita a. Cancer Chemother Pharmacol. 2001 Dec;48(6):446-50. doi: 10.1007/s002800100369. Cancer Chemother Pharmacol. 2001. PMID: 11800024 Clinical Trial.
852 results